Shares of Hims & Hers tumble 26% after FDA says se... CNBC

Shares of Hims & Hers tumble 26% after FDA says semaglutide is no longer in shortage

CNBC February 21, 2025
Upvote 0 Downvote

Shares of Hims & Hers tumble 26% after FDA says semaglutide is no longer in shortage

Read Full Article

Comments 0

Log in to post a comment.

No comments yet. Be the first to comment!

Related News
Source Information
CNBC

Published on February 21, 2025

Visit Source
Advertise with Us

Reach our audience with your ads